# Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications

> **NCT07410988** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Seoul National University Hospital** · enrollment: 1292 (estimated)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** Volulyte® (6% HES 130/0.4 in balanced solution)
- **DRUG:** Crystalloid solutions

## Key facts

- **NCT ID:** NCT07410988
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 1292 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07410988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07410988, "Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07410988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*